Category: Biotherapeutics

Biotherapeutics startup Hummingbird Bioscience brings its total Series B funding to $25 million
, ,

Biotherapeutics startup Hummingbird Bioscience brings its total Series B funding to $25 million

Hummingbird Bioscience, a startup focused on developing new treatments for cancer and other diseases, announced today it has added $6 million to its previously announced Series B, bringing the round’s total to $25 million. The extension was led by SK Holdings, and included participation from returning investors including Heritas Capital and SEEDS Capital, the investment…

Read More